The Weizmann Institute: a family affair
In establishing the Dr. Dvora and Haim Teitelbaum Endowment Fund, siblings Sagit Shiran and Shay Teitelbaum said their intention is to help cultivate the connection between basic research and clinical applications through a fund that seeds biomedical research collaborations with hospitals. Shiran and Teitelbaum are the children of Dr. Dvora Teitelbaum, a former scientist at the Weizmann Institute who, together with Profs. Ruth Arnon and Michael Sela, performed pioneering scientific research that led to the creation of Copaxone®, a blockbuster drug for the treatment of multiple sclerosis.
Dr. Rotem Sorek of the Department of Molecular Genetics, who received support from the Teitelbaum Fund, spoke about his research on “microbial warfare”: the mechanisms by which microorganisms attack one another and defend themselves.